Vivex Biomedical, Inc. — Form D

Vivex Biomedical, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-05. The offering totals $10.0M, of which $6.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Barry J SalzmanDirectorMarietta, GA
Jeffrey A SmithDirectorCarrollton, GA
Timothy J TaylorDirectorSacramento, CA
Timothy J Ganey, Ph.D.Executive OfficerMarietta, GA
THOMAS J GIBSONExecutive OfficerATLANTA, GA
Ricardo J NunezExecutive OfficerMarietta, GA
Dr. H. Thomas TempleExecutive OfficerMarietta, GA
Tracy AndersonDirectorLos Angeles, CA
Tracy AndersonExecutive OfficerLos Angeles, CA
John MarshExecutive OfficerHouston, TX
Michael RozmajzlExecutive OfficerMilton, GA
TIMOTHY TAYLORDirectorNew York, NY
Richard E PerlmanDirectorCHICAGO, IL
James K PriceDirectorCHICAGO, IL
Timothy Thomas Ganey, Ph.D.Executive OfficerAtlanta, GA
Holly S MasonExecutive OfficerAtlanta, GA
John A McCallumDirectorAtlanta, GA
Barry Thomas SalzmanDirectorAtlanta, GA
Dr. H Thomas TempleExecutive OfficerAtlanta, GA
Tracy S AndersonDirectorAtlanta, GA
Tracy S AndersonExecutive OfficerAtlanta, GA
J. Miguel Fernandez de CastroDirectorAtlanta, GA
Timothy S TaylorDirectorAtlanta, GA
U. Bertram Ellis, Jr.DirectorAtlanta, GA
Stuart J KomenskiExecutive OfficerAtlanta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2017-05-11D/A$7.0M$6.3M
2017-01-26D$5.0M
2013-09-16D/A$7.2M$7.2M
2013-07-18D$5.5M$2.2M

More